Volume 68 Received 26 October 2012 | ||||||||||
| ||||||||||
aNational Institute of Technology-Karnataka, Department of Chemistry, Medicinal Chemistry Laboratory, Surathkal, Mangalore 575 025, India,bTechnion Israel Institute of Technology, Schulich Faculty of Chemistry, Haifa, 32000, Israel, and cNelson Mandela Metropolitan University, Summerstrand Campus, Department of Chemistry, University Way, Summerstrand, PO Box 77000, Port Elizabeth, 6031, South Africa
Correspondence e-mail: richard.betz@webmail.co.za
The title compound, C24H18BrF3N4O4, is a 1,2,3-triazole derivative featuring, among others, a quinoline-derived substituent. In the crystal, C-H
O, C-H
N and C-H
F contacts connect the molecules into a three-dimensional network. The shortest centroid-centroid distance between two aromatic systems is 3.896 (2) Å and is found between the two different six-membered rings of the quinoline scaffold in neighbouring molecules.
For background to the industrial importance of heterocyclic compounds, see: Isloor et al. (2009
); Vijesh et al. (2011
); Ruanwasa et al. (2010
). For pharmacological properties of quinoline-derived compounds, see: Chen et al. (2004
); Kaur et al. (2010
); Bekhit et al. (2004
). For graph-set analysis of hydrogen bonds, see: Etter et al. (1990
); Bernstein et al. (1995
).
|
|
|
Data collection: APEX2 (Bruker, 2010
); cell refinement: SAINT (Bruker, 2010
); data reduction: SAINT; program(s) used to solve structure: SHELXS97 (Sheldrick, 2008
); program(s) used to refine structure: SHELXL97 (Sheldrick, 2008
); molecular graphics: ORTEP-3 (Farrugia, 2012
) and Mercury (Macrae et al., 2008
); software used to prepare material for publication: SHELXL97 and PLATON (Spek, 2009
).
Supplementary data and figures for this paper are available from the IUCr electronic archives (Reference: IM2409 ).
AMI thanks the Board for Research in Nuclear Sciences, Department of Atomic Energy, Government of India, for the Young Scientist award.
Bekhit, A. A., El-Sayed, O. A., Aboulmagd, E. & Park, J. Y. (2004). Eur. J. Med. Chem. 39, 249-255.
![[ChemPort]](../../../../../../logos/chemportborder.gif)
Bernstein, J., Davis, R. E., Shimoni, L. & Chang, N.-L. (1995). Angew. Chem. Int. Ed. Engl. 34, 1555-1573.
![[ISI]](../../../../../../logos/isiborder.gif)
Bruker (2008). SADABS. Bruker Inc., Madison, Wisconsin, USA.
Bruker (2010). APEX2 and SAINT. Bruker AXS Inc., Madison, Wisconsin, USA.
Chen, Y. L., Hung, H. M., Lu, C. M., Li, K. C. & Tzeng, C. C. (2004). Bioorg. Med. Chem. 12, 6539-6546.
![[ChemPort]](../../../../../../logos/chemportborder.gif)
Etter, M. C., MacDonald, J. C. & Bernstein, J. (1990). Acta Cryst. B46, 256-262.
![[details]](../../../../../../b/graphics/details.gif)
Farrugia, L. J. (2012). J. Appl. Cryst. 45, 849-854.
![[details]](../../../../../../j/graphics/details.gif)
Isloor, A. M., Kalluraya, B. & Shetty, P. (2009). Eur. J. Med. Chem. 44, 3784-3787.
![[ChemPort]](../../../../../../logos/chemportborder.gif)
Kaur, K., Jain, M., Reddy, R. P. & Jain, R. (2010). Eur. J. Med. Chem. 45, 3245-3264.
![[PubMed]](../../../../../../logos/pubmedborder.gif)
Macrae, C. F., Bruno, I. J., Chisholm, J. A., Edgington, P. R., McCabe, P., Pidcock, E., Rodriguez-Monge, L., Taylor, R., van de Streek, J. & Wood, P. A. (2008). J. Appl. Cryst. 41, 466-470.
![[details]](../../../../../../j/graphics/details.gif)
Ruanwas, P., Kobkeatthawin, T., Chantrapromma, S., Fun, H.-K., Philip, R., Smijesh, N., Padaki, M. & Isloor, A. M. (2010). Synth. Met. 160, 819-824.
![[ChemPort]](../../../../../../logos/chemportborder.gif)
Sheldrick, G. M. (2008). Acta Cryst. A64, 112-122.
![[details]](../../../../../../a/graphics/details.gif)
Spek, A. L. (2009). Acta Cryst. D65, 148-155.
![[details]](../../../../../../d/graphics/details.gif)
Vijesh, A. M., Isloor, A. M., Peethambar, S. K., Shivananda, K. N., Arulmoli, T. & Isloor, N. A. (2011). Eur. J. Med. Chem. 46, 5591-5597.
![[PubMed]](../../../../../../logos/pubmedborder.gif)